menu search

Multiple promising treatments accentuate the bull case for sunshine biopharma

SBFM stock is trading at a surprisingly low price, considering Sunshine Biopharma's demonstrably positive clinical results. The post Multiple Promisin...

April 26, 2022, 8:13 am

Nkarta scores huge gain on cancer treatment results

Bargain hunters may want to feast their eyes on a South San Francisco-based biotech focusing on cancer treatme...

April 25, 2022, 5:04 pm

Nkarta stock skyrockets on heavy volume after upbeat results from cancer-treatment trial

Shares of Nkarta Inc. NKTX, +95.82% skyrocketed 92.8% in very active morning trading, enough to make the stock the biggest gainer and most active list...

April 25, 2022, 10:49 am

Seastar medical is getting nasdaq listing via a merger with lmao

SeaStar Medical Inc, a medical tech corporation focusing on the development of extracorporeal therapy treatme...

April 23, 2022, 7:14 am

Pfizer: what comes after the covid-19 fire?

Pfizer now has a $31 billion warchest that incoming CFO David Denton must spend on treatments that can ...

April 21, 2022, 8:00 pm

Edesa biotech: leader in developing treatments for covid-19 and acd

Edesa is one of 4 pharmaceutical companies that received a grant from the Canadian government to develop a drug to treat COVID-19. EB01 achieved all e...

April 18, 2022, 1:53 pm

Revive therapeutics updates further on its phase 3 bucillamine in coronavirus trial

Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) has updated on its Phase 3 clinical trial for Bucillamine in coronavirus (COVID-19), saying it is still...

April 12, 2022, 8:01 am

Mrna cancer treatment: covid vaccine giant biontech touts promising early data

An mRNA vaccine can potentially boost cell treatments used to fight blood cancer and make them more eff...

April 11, 2022, 12:49 pm

Antibody treatments for covd-19 face challenges in the u.s.

With the emergence of the highly transmissible Omicron variant, the authorized antibody treatments of c...

April 8, 2022, 10:32 am

Astrazeneca has cracked a whole new cancer treatment market, but how much is worth?

Research on AstraZeneca PLC (LSE:AZN) by JP Morgan underlined the scale of the opportunity on offer for the micro-cap life sciences companies developi...

April 7, 2022, 8:38 am

Betterlife says betr-001 demonstrates strong anti-depressant activity in preclinical models of depression

BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF), a biotech company focused on the development and commercialization of cutting-edge ...

April 6, 2022, 1:03 pm

Baxter's (bax) st set receives fda nod, to boost patient outcome

Baxter's (BAX) ST Set is expected to improve treatments in an acute care environment....

April 6, 2022, 12:48 pm

Ocuphire pharma to present at wet amd & dme drug development summit in boston, ma

FARMINGTON HILLS, Mich., April 06, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical compan...

April 6, 2022, 8:00 am

Aslan pharmaceuticals to present at the annual needham virtual healthcare conference 2022

MENLO PARK, Calif. and SINGAPORE, April 06, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage, immunology-focused biophar...

April 6, 2022, 7:00 am

Mgc pharmaceuticals agrees european distribution deal for cannabinoid treatments

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has signed an exclusive distribution for the UK and certain EU countries for its proprietary can...

April 5, 2022, 3:00 am

Mydecine ends fy2021 with c$1.5m in cash to help propel mental health treatment initiatives in 2022

Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) ended 2021 with C$1.5 million in cash and decribed the just-ended financial year as one in which...

April 1, 2022, 9:26 am

Phathom pharmaceuticals to present at the 21st annual needham virtual healthcare conference

FLORHAM PARK, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company f...

April 1, 2022, 8:01 am

Vyant bio enters collaboration with organotherapeutics to find treatments for parkinson's disease

Vyant Bio (NASDAQ:VYNT) Inc said it has entered into a collaboration agreement with OrganoTherapeutics to accelerate the discovery of drugs to treat P...

March 30, 2022, 7:20 am

Tyme technologies shares jump premarket on news board to explore strategic options

Tyme Technologies Inc. TYME, -5.56% , a biotech developing cancer metabolism-based treatments, said Tue...

March 29, 2022, 8:01 am

Iovance biotherapeutics: an unproven biopharmaceutical company with significant upside

Iovance Biotherapeutics focuses on developing treatments for cancers, a market with minimal supply and ...

March 25, 2022, 3:46 am


Search within

Pages Search Results: